Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin ophthalmic solution, 0...

Full Story →